CirTran Corporation (CIRX)

Import this data to Google Sheets with:

=jivedata("CIRX","financials")

Full statements spill as a table. For one cell: =jivedata("CIRX","Revenue") or =jivedata("CIRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CirTran Corporation

CIRX • CIK 0000813716

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$1,616.148	$1,296.796	$3,126.891	$4,830.659
Cost of Goods and Services Sold	$609.651	$458.158	$1,586.194	$2,562.792
Gross Profit	$1,006.497	$838.638	$1,540.697	$2,267.867
Operating Expenses	$1,021.414	$1,389.377	$1,670.42	$1,964.309
Operating Income (Loss)	$-14.917	$-550.739	$-129.723	$303.558
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	—	—	$-548.168	$-76.661
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$20,831.526	$-153.886	$-153.466	$2,196.667
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$20,279.827	$-2,701.24	$-701.634	$2,120.006
Income Tax Expense (Benefit)	$-8.533	$-74.364	$-74.364	$-74.364
Net Income (Loss) Attributable to Parent	$20,288.36	$-2,626.876	$-701.634	$2,129.329
Weighted Average Number of Shares Outstanding, Basic	4,945,417	4,945,417	4,945,417	4,945,417
Labor and Related Expense	$511.519	$515.807	$508.553	$515.686
Selling, General and Administrative Expense	$509.895	$873.57	$1,161.867	$1,448.623
InterestExpenseNonoperating	—	$790.589	$822.735	$843.514
Gain (Loss) on Extinguishment of Debt	$328.384	$328.384	$19.859	$20.229
Gain (Loss) on Disposition of Property Plant Equipment	—	$7.222	$-9.323	$-9.323
Derivative, Gain (Loss) on Derivative, Net	$-292.1	$-1,161.498	$64.891	$123.532
Other Nonoperating Income	$1.124	$0.25	$0.006	$0.006
Nonoperating Income (Expense)	$-536.782	$-1,996.615	$-418.445	$-380.219

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Investment Owned, at Cost	$300	$248	$248	$248
Property, Plant and Equipment, Net	$18.925	$6.407	$4.607	$3.465
Assets	$1,848.562	$1,532.332	$2,514.031	$2,603.525
Deferred Income Tax Liabilities, Net	$55.946	$55.946	—	$27.443
Notes Payable, Noncurrent	$634.636	$643	$643	$643
Convertible Debt, Noncurrent	$2,077.934	$2,177.723	$2,283.844	$2,338.397
Liabilities	$23,627.247	$25,937.893	$27,621.226	$25,597.943
Cash	$18.081	—	$9.589	$158.137
Inventory, Net	$815.612	$737.223	$1,136.546	$1,032.17
Accounts Receivable, after Allowance for Credit Loss, Current	$21.536	$25.641	$365.661	$480.118
Other Assets, Current	$441.095	$485.621	$468.34	$473.363
Assets, Current	$1,529.637	$1,277.925	$2,261.424	$2,352.06
Accounts Payable, Current	—	$762.44	$149.448	$127.37
Bank Overdrafts	—	$30.384	$30.384	$30.384
Accrued Liabilities, Current	$2,889.389	$2,776.008	$2,758.884	$2,640.845
Employee-related Liabilities, Current	$5,067.213	$5,381.549	$5,674.164	$5,784.805
Interest Payable, Current	$5,758.603	$6,281.805	$6,739.423	$7,048.884
Convertible Debt, Current	$264.284	$264.284	$264.284	$264.284
Derivative Liability, Current	$1,296.937	$2,458.435	$2,393.544	$2,330.519
Disposal Group, Including Discontinued Operation, Liabilities, Current	$4,511.075	$4,664.96	$4,818.427	$2,544.396
Liabilities, Current	$20,858.731	$23,117.17	$24,694.382	$22,616.546
Common Stock, Value, Issued	$4.945	$4.945	$4.945	$4.945
Additional Paid in Capital, Common Stock	$37,233.561	$37,233.561	$37,233.561	$37,233.561
Retained Earnings (Accumulated Deficit)	$-59,017.191	$-61,644.067	$-62,345.701	$-60,232.924
Stockholders' Equity Attributable to Parent	$-21,778.685	$-24,405.561	$-25,107.195	$-22,994.418
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	4,945,417	4,945,417	4,945,417	4,945,417

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$20,288.36	$-2,626.876	$-701.634	$2,129.329
Net Cash Provided by (Used in) Operating Activities	$-72.607	$-46.354	$-1,338.174	$-586.5
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	—	$-18.081	$9.589	$153.802
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$18.081	$18.081	$9.589	$19.715
Proceeds from Sale of Property, Plant, and Equipment	—	$15.4	$15.4	$15.4
Depreciation	$4.507	$4.34	$1.8	$1.955
Net Cash Provided by (Used in) Investing Activities	$-8.414	$15.4	$15.4	$15.4
Derivative, Gain (Loss) on Derivative, Net	$-292.1	$-1,161.498	$64.891	$123.532
Amortization of Debt Discount (Premium)	$109.624	$99.788	$106.12	$108.706
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property	—	—	$7.222	$7.222
Gain (Loss) on Extinguishment of Debt	$328.384	$328.384	$19.859	$20.229
Proceeds from (Repayments of) Bank Overdrafts	—	—	$-30.384	$-30.384
Proceeds from Related Party Debt	$114.6	$61.906	$1,378.147	$740.302
Repayments of Related Party Debt	$47.478	$61.336	$61.336	$61.336
Net Cash Provided by (Used in) Financing Activities	$62.94	$30.954	$1,347.763	$740.302
Increase (Decrease) in Inventories	$-0.402	$-78.389	$399.323	$195.705
Increase (Decrease) in Deposit Assets	$-13.457	$1.82	$252.485	$182.671
Increase (Decrease) in Accounts Receivable	$-41.337	$4.105	$340.02	$463.41
Increase (Decrease) in Other Current Assets	$112.627	$44.526	$-17.281	$-32.009
Increase (Decrease) in Accounts Payable	$-1,188.715	$134.958	$-264.276	$-290.466
Increase (Decrease) in Accrued Liabilities	$810.136	$-113.383	$-17.122	$261.503
Increase (Decrease) in Income Taxes	—	—	$-55.946	$-55.946
Increase (Decrease) in Employee Related Liabilities	$272.377	$314.336	$292.615	$258.774
Increase (Decrease) in Interest Payable, Net	$544.073	$523.202	$457.618	$462.124

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CIRX","financials")

Full statements spill as a table. For one cell: =jivedata("CIRX","Revenue") or =jivedata("CIRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.